AstraZeneca PLC (FRA:ZEG)
126.95
+0.60 (0.47%)
Last updated: Sep 29, 2025, 5:42 PM CET
AstraZeneca Revenue
AstraZeneca had revenue of $14.46B USD in the quarter ending June 30, 2025, with 11.74% growth. This brings the company's revenue in the last twelve months to $56.50B, up 15.00% year-over-year. In the year 2024, AstraZeneca had annual revenue of $54.07B with 18.03% growth.
Revenue (ttm)
$56.50B
Revenue Growth
+15.00%
P/S Ratio
4.10
Revenue / Employee
$599.16K
Employees
94,300
Market Cap
197.31B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 54.07B | 8.26B | 18.03% |
Dec 31, 2023 | 45.81B | 1.46B | 3.29% |
Dec 31, 2022 | 44.35B | 6.93B | 18.53% |
Dec 31, 2021 | 37.42B | 10.80B | 40.58% |
Dec 31, 2020 | 26.62B | 2.23B | 9.16% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.89B |
Siemens Aktiengesellschaft | 78.30B |
Deutsche Telekom AG | 120.55B |
Allianz SE | 109.02B |
Rheinmetall AG | 10.67B |
Siemens Energy AG | 38.39B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.33B |
Deutsche Bank Aktiengesellschaft | 30.07B |
AstraZeneca News
- 4 days ago - A New Prescription For Pain: Understanding Trump's 100% Pharma Tariff - Seeking Alpha
- 4 days ago - AstraZeneca to Offer Discounted Drugs As Trump Pressures Pharma Industry to Cut Prices - WSJ
- 4 days ago - AstraZeneca launches direct-to-consumer platform to expand access to medications for US patients, including those living with chronic conditions - Business Wire
- 4 days ago - AstraZeneca to cut some direct-to-patient US drug prices after Trump demand - Reuters
- 5 days ago - AstraZeneca: Oncology Breakthroughs And Farxiga Surge Excite Investors - Seeking Alpha
- 6 days ago - Moderna boss defends UK in drug-pricing row as he opens £150m Oxfordshire facility - The Guardian
- 6 days ago - AstraZeneca (AZN) Receives FDA Priority Review for Enhertu - GuruFocus
- 6 days ago - AstraZeneca, Daiichi Sankyo under priority review of FDA for breast cancer - Seeking Alpha